Additionally, CSF1 expression correlates with accumulation of CD8+ T cells and CD163+ TAMs in melanoma, and anti−PD1 and anti−CSF1R combination therapy induced regression of melanoma in preclinical studies (195). The gene discussed is CD163; the disease is melanoma.